293 related articles for article (PubMed ID: 12392154)
1. Low molecular weight hyaluronan induces malignant mesothelioma cell (MMC) proliferation and haptotaxis: role of CD44 receptor in MMC proliferation and haptotaxis.
Nasreen N; Mohammed KA; Hardwick J; Van Horn RD; Sanders K; Kathuria H; Loghmani F; Antony VB
Oncol Res; 2002; 13(2):71-8. PubMed ID: 12392154
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells.
Asplund T; Heldin P
Cancer Res; 1994 Aug; 54(16):4516-23. PubMed ID: 7519123
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan production increases the malignant properties of mesothelioma cells.
Li Y; Heldin P
Br J Cancer; 2001 Aug; 85(4):600-7. PubMed ID: 11506502
[TBL] [Abstract][Full Text] [Related]
4. Chondrocytes are regulated by cellular adhesion through CD44 and hyaluronic acid pathway.
Ishida O; Tanaka Y; Morimoto I; Takigawa M; Eto S
J Bone Miner Res; 1997 Oct; 12(10):1657-63. PubMed ID: 9333126
[TBL] [Abstract][Full Text] [Related]
5. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix.
Zhu H; Mitsuhashi N; Klein A; Barsky LW; Weinberg K; Barr ML; Demetriou A; Wu GD
Stem Cells; 2006 Apr; 24(4):928-35. PubMed ID: 16306150
[TBL] [Abstract][Full Text] [Related]
6. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
7. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion.
Turley EA; Austen L; Moore D; Hoare K
Exp Cell Res; 1993 Aug; 207(2):277-82. PubMed ID: 7688314
[TBL] [Abstract][Full Text] [Related]
8. Expression levels and functional aspects of the hyaluronan receptor CD44. Effects of insulin, glucose, IGF-I, or growth hormone on human arterial smooth muscle cells.
Schultz K; Rasmussen LM; Ledet T
Metabolism; 2005 Mar; 54(3):287-95. PubMed ID: 15736104
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.
Wang SJ; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188
[TBL] [Abstract][Full Text] [Related]
10. Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells.
Nasreen N; Mohammed KA; Antony VB
Cancer; 2006 Nov; 107(10):2425-35. PubMed ID: 17041885
[TBL] [Abstract][Full Text] [Related]
11. Role of hyaluronan and CD44 in in vitro branching morphogenesis of ureteric bud cells.
Pohl M; Sakurai H; Stuart RO; Nigam SK
Dev Biol; 2000 Aug; 224(2):312-25. PubMed ID: 10926769
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes.
Bourguignon LY; Gilad E; Peyrollier K; Brightman A; Swanson RA
J Neurochem; 2007 May; 101(4):1002-17. PubMed ID: 17403031
[TBL] [Abstract][Full Text] [Related]
13. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
English NM; Lesley JF; Hyman R
Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90.
Zhang Y; Thant AA; Machida K; Ichigotani Y; Naito Y; Hiraiwa Y; Senga T; Sohara Y; Matsuda S; Hamaguchi M
Cancer Res; 2002 Jul; 62(14):3962-5. PubMed ID: 12124327
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
16. Tumour regulation of fibroblast hyaluronan expression: a mechanism to facilitate tumour growth and invasion.
Edward M; Gillan C; Micha D; Tammi RH
Carcinogenesis; 2005 Jul; 26(7):1215-23. PubMed ID: 15746159
[TBL] [Abstract][Full Text] [Related]
17. The effect of different molecular weight hyaluronan on macrophage physiology.
Krejcova D; Pekarova M; Safrankova B; Kubala L
Neuro Endocrinol Lett; 2009; 30 Suppl 1():106-11. PubMed ID: 20027154
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
Afify AM; Stern R; Michael CW
Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
[TBL] [Abstract][Full Text] [Related]
19. CD44 mediates oligosaccharides of hyaluronan-induced proliferation, tube formation and signal transduction in endothelial cells.
Wang YZ; Cao ML; Liu YW; He YQ; Yang CX; Gao F
Exp Biol Med (Maywood); 2011 Jan; 236(1):84-90. PubMed ID: 21239738
[TBL] [Abstract][Full Text] [Related]
20. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
Liao HX; Lee DM; Levesque MC; Haynes BF
J Immunol; 1995 Oct; 155(8):3938-45. PubMed ID: 7561101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
